Narrative Exposure Therapy Versus Group Interpersonal Psychotherapy

This study has been terminated.
Sponsor:
Collaborator:
vivo
Information provided by:
University of Konstanz
ClinicalTrials.gov Identifier:
NCT00623298
First received: February 14, 2008
Last updated: February 25, 2008
Last verified: February 2008
  Purpose

The present study is a pragmatic trial that investigates the efficacy and usefulness of two treatment modules in a sample of Rwandan genocide orphans: Narrative Exposure Therapy (NET) versus group-Interpersonal Psychotherapy (IPT). We used a half year baseline to measure the treatment-induced changes. We hypothesized that there would be a greater reduction in posttraumatic stress symptoms in the NET- than in the IPT-group and that IPT would be superior to NET in the reduction of depression symptoms.


Condition Intervention Phase
Posttraumatic Stress Disorder
Depression
Narrative Exposure Therapy
Interpersonal Psychotherapy
Behavioral: Narrative Exposure Therapy
Behavioral: group IPT
Other: 6 months-baseline
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Narrative Exposure Therapy Versus Group Interpersonal Psychotherapy -A Controlled Clinical Trial With Orphaned Survivors of the Rwandan Genocide

Resource links provided by NLM:


Further study details as provided by University of Konstanz:

Primary Outcome Measures:
  • Symptoms of posttraumatic stress disorder, symptoms of depression

Enrollment: 26
Study Start Date: January 2005
Study Completion Date: March 2006
Arms Assigned Interventions
Experimental: 1
NET
Behavioral: Narrative Exposure Therapy
No Intervention: 3
6-months baseline
Other: 6 months-baseline
Experimental: 2
group IPT
Behavioral: group IPT

Detailed Description:

The 1994 genocide of Rwanda has left countless children orphaned. 26 Rwandan orphans who fulfilled DSM-IV diagnosis of PTSD were offered participation in a controlled treatment trial. A group adaptation of Interpersonal Psychotherapy (IPT, n = 14) was compared to Narrative Exposure Therapy (NET, n = 12). Main outcome measures were symptoms of PTSD and depression assessed pre-treatment, 3 months after therapy (post-test) and 6 months after therapy (follow-up) using the CAPS, MINI and Hamilton Rating Scale. At post-test, participants in both treatment conditions showed reductions in posttraumatic stress symptoms and depression symptoms. At 6-month follow-up, NET proved to be more effective in the treatment of PTSD. Only 25% (n = 3) of NET-participants but 71% (n = 10) of the IPT-participants still fulfilled PTSD criteria at follow-up. Although there was a significant reduction in depression symptoms in both treatment groups from pre-test to follow-up, NET again proved to be more effective. This treatment-trial demonstrates that NET and group-IPT are suitable treatment modules even when most severe traumatic stress and difficult living conditions have led to chronic mental suffering.

  Eligibility

Ages Eligible for Study:   13 Years to 29 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Rwandan orphans who have experienced the genocide, who lost at least one parent during the genocide and who were no older than 18 years during the genocide

Exclusion Criteria:

  • Mental retardation
  • Psychotic symptoms or current drug or alcohol
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Dr. Susanne Schaal, University of Konstanz, vivo
ClinicalTrials.gov Identifier: NCT00623298     History of Changes
Other Study ID Numbers: Fogr SOSS
Study First Received: February 14, 2008
Last Updated: February 25, 2008
Health Authority: University of Konstanz: Germany

Keywords provided by University of Konstanz:
Posttraumatic stress disorder
depression
Narrative Exposure Therapy
Interpersonal Psychotherapy

Additional relevant MeSH terms:
Depression
Depressive Disorder
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Behavioral Symptoms
Mood Disorders
Mental Disorders
Anxiety Disorders

ClinicalTrials.gov processed this record on April 16, 2014